Dr Nataly Stylianou

2024

• Stylianou, N., Sebina, I., Matigian, N., Monkman, J., Doehler, H., Röhl, J., Allenby, M., Nam, A., Pan, L., Rockstroh, A., Sadeghirad, H., Chung, K., Sobanski, T., O'Byrne, K., Almeida, A. C. S. F., Rebutini, P. Z., Machado-Souza, C., Stonoga, E. T. S., Warkiani, M. E., Salomon, C., Short, K., McClements, L., de Noronha, L., Huang, R., Belz, G. T., Souza-Fonseca-Guimaraes, F., Clifton, V. & Kulasinghe, A. (2024). Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures. Clinical and Translational Immunology, Article e1488, 13(2). https://eprints.qut.edu.au/246626

2022

• Rad, H. S., Röhl, J., Stylianou, N., Allenby, M. C., Bazaz, S. R., Warkiani, M. E., Guimaraes, F. S. F., Clifton, V. L. & Kulasinghe, A. (2022). Corrigendum: The effects of COVID-19 on the placenta during pregnancy (Front. Immunol., (2021), 12, (743022), 10.3389/fimmu.2021.743022). Frontiers in Immunology, 13.

2021

• Rad, H. S., Rohl, J., Stylianou, N., Allenby, M. C., Bazaz, S. R., Warkiani, M. E., Guimaraes, F. S. F., Clifton, V. L. & Kulasinghe, A. (2021). The Effects of COVID-19 on the Placenta During Pregnancy. Frontiers in Immunology, 12. https://eprints.qut.edu.au/229961

2019

• Stylianou, N., Lehman, M., Wang, C., Taherian Fard, A., Rockstroh, A., Fazli, L., Jovanovic, L., Ward, M., Sadowski, M., Kashyap, A., Buttyan, R., Gleave, M., Westbrook, T., Williams, E., Gunter, J., Nelson, C. & Hollier, B. (2019). A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome. Oncogene, 38(7), 913–934. https://eprints.qut.edu.au/121398
• Sarkar, P. L., Lee, W., Williams, E., Lubik, A., Stylianou, N., Shokoohmand, A., Lehman, M., Hollier, B., Gunter, J. & Nelson, C. (2019). Insulin enhances migration and invasion in prostate cancer cells by up-regulation of FOXC2. Frontiers in Endocrinology, Article 481, 10, 1–16. https://eprints.qut.edu.au/133371
• Stylianou, N., Lehman, M. L., Wang, C., Fard, A. T., Rockstroh, A., Fazli, L., Jovanovic, L., Ward, M., Sadowski, M. C., Kashyap, A. S., Buttyan, R., Gleave, M. E., Westbrook, T. F., Williams, E. D., Gunter, J. H., Nelson, C. C. & Hollier, B. G. (2019). Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome. Oncogene, 38(13).

2018

• Pillman, K., Phillips, C., Roslan, S., Toubia, J., Dredge, B. K., Bert, A., Lumb, R., Neumann, D., Li, X., Conn, S., Liu, D., Bracken, C., Lawrence, D., Stylianou, N., Schreiber, A., Tilley, W., Hollier, B., Khew-Goodall, Y., Selth, L. & Goodall, G. (2018). miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO Journal, Article e99016, 37(13), 1–20. https://eprints.qut.edu.au/122452
• Stylianou, N., Lehman, M. L., Wang, C., Jovanovic, L., Rockstroh, A., Fard, A. T., Kashyap, A., Fazli, L., Buttyan, R., Gleave, M., Westbrook, T. F., Williams, E. D., Gunter, J. H., Nelson, C. C. & Hollier, B. G. (2018). Revealing the transcriptional landscape of epithelial-mesenchymal plasticity in mCRPC. BJU International, 122(Suppl. 2), 35. https://eprints.qut.edu.au/211953

2017

• Selth, L., Das, R., Townley, S., Coutinho, I., Hanson, A., Centenera, M. M., Stylianou, N., Sweeney, K., Jovanovic, L., Nelson, C., Hollier, B. & other (2017). A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer. Oncogene, 36(1), 24–34. https://eprints.qut.edu.au/102387
• Tse, B., Volpert, M., Ratther, E., Stylianou, N., Nouri, M., McGowan, K., Lehman, M., McPherson, S., Roshan-Moniri, M., Butler, M., Caradec, J., Gregory-Evans, C., McGovern, J., Williams, E., Gunter, J., Russell, P., Nelson, C., Hollier, B. & other (2017). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene, 36(24), 3417–3427. https://eprints.qut.edu.au/107515
• Sweeney, K. G., Stylianou, N., Tevz, G., Taherianfard, A., Pirlo, K., Upadhyaya, A., Ratther, E., Lehman, M., Gleave, M., Gunter, J., Williams, E. D., Nelson, C. C. & Hollier, B. (2017). Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance. Cancer Research, 77(Suppl. 13). https://eprints.qut.edu.au/211956

2015

• Sweeney, K., Stylianou, N., Tevz, G., Pirlo, K., Upadhyaya, A., Lehman, M., Fazli, L., Gleave, M., Gunter, J., Williams, E. D., Nelson, C. C. & Hollier, B. G. (2015). Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer. 35.
• Panchadsaram, J., Tevz, G., Stylianou, N., Hollier, B. G. & Nelson, C. (2015). A multiple nucleotide length polymorphism (MNLP) mediates androgen regulation of IRX4 in prostate cancer. 36.
• Rather, E., Sweeney, K., Stylianou, N., Nelson, C., Williams, E. D. & Hollier, B. G. (2015). Investigating the role of neuroendocrine transdifferentiation in the progression to castration resistant prostate cancer. 40.
• Volpert, M., Tse, B. W. C., Stylianou, N., Ratther, E., McPherson, S., Costa, T., McGowan, K., Lehman, M., Fazli, L., Gleave, M., Russell, P., Gunter, J. H., Williams, E. D., Nelson, C. & Hollier, B. G. (2015). Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis. 40.